Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACHILLION PHARMACEUTICALS INC | 250,000 | reported | 09 Feb 2018 | tx 32+1,575,875−160,250 |
| Cullinan Therapeutics, Inc. | 126,380 | reported | 20 Feb 2026 | tx 7+586,277−4,398 |
| Talaris Therapeutics, Inc. | 68,054 | reported | 03 Jul 2023 | tx 6+581,000−12,946 |
| Oncorus, Inc. | 12,500 | reported | 23 Jun 2022 | tx 2+25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 4,398 | 13.62 USD | |
| 18 Feb 2026 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 68,750 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 137,500 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 27 | 6.49 USD | |
| 19 Feb 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 60,000 | 0.00 USD | |
| 19 Feb 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 29 Apr 2024 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 03 Jul 2023 | TAX_WITHHOLDING | Talaris Therapeutics, Inc. | 12,946 | 3.08 USD | |
| 01 Feb 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 01 Feb 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 10 Sept 2022 | GRANT_AWARD | Talaris Therapeutics, Inc. | 80,000 | 0.00 USD | |
| 23 Jun 2022 | GRANT_AWARD | Oncorus, Inc. | 12,500 | 0.00 USD | deriv |
| 31 Dec 2021 | GRANT_AWARD | Talaris Therapeutics, Inc. | 1,000 | 13.00 USD | |
| 01 Feb 2022 | GRANT_AWARD | Talaris Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Oncorus, Inc. | 12,500 | 0.00 USD | deriv |
| 09 Feb 2018 | GRANT_AWARD | ACHILLION PHARMACEUTICALS INC | 250,000 | 0.00 USD | deriv |
| 17 Jan 2017 | GRANT_AWARD | ACHILLION PHARMACEUTICALS INC | 165,000 | 0.00 USD | deriv |
| 05 Dec 2016 | PURCHASE | ACHILLION PHARMACEUTICALS INC | 2,500 | 4.11 USD | |
| 20 Jan 2016 | GRANT_AWARD | ACHILLION PHARMACEUTICALS INC | 118,000 | 0.00 USD | deriv |
| 28 Dec 2015 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 43,500 | 1.05 USD | |
| 28 Dec 2015 | SALE | ACHILLION PHARMACEUTICALS INC | 43,500 | 10.08 USD | |
| 28 Dec 2015 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 43,500 | 0.00 USD | deriv |
| 23 Jan 2015 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 13,125 | 4.00 USD | |
| 23 Jan 2015 | SALE | ACHILLION PHARMACEUTICALS INC | 13,125 | 16.00 USD | |
| 23 Jan 2015 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 13,125 | 0.00 USD | deriv |